vimarsana.com

Latest Breaking News On - Fundamental investments - Page 4 : vimarsana.com

Pixelworks, Inc. (NASDAQ:PXLW) Short Interest Down 46.4% in May

Pixelworks, Inc. (NASDAQ:PXLW – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 275,700 shares, a decline of 46.4% from the April 30th total of 514,400 shares. Based on an average daily volume of 603,100 shares, the […]

Taiwan
China
United-states
Japan
Todd-debonis
Roth-mkm
Craig-hallum
Susquehanna-fundamental-investments
Essex-investment-management-co
Nasdaq
Sg-americas-securities
Traynor-capital-management-inc

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Short Interest Up 143.1% in May

CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 8,750,000 shares, an increase of 143.1% from the April 30th total of 3,600,000 shares. Based on an average trading volume of 6,480,000 shares, […]

Piper-sandler
Seana-mccarthy
Cytomx-therapeutics-company-profile
Sg-americas-securities
Alphamark-advisors
York-mellon-corp
Congress-park-capital
Cytomx-therapeutics-inc
Nasdaq
Jefferies-financial-group
Susquehanna-fundamental-investments
Securities-exchange-commission

Aeva Technologies (NYSE:AEVA) Stock Price Down 4.1%

Aeva Technologies, Inc. (NYSE:AEVA – Get Free Report) shares dropped 4.1% during trading on Wednesday . The stock traded as low as $3.14 and last traded at $3.17. Approximately 196,528 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 324,934 shares. The stock had previously closed at $3.30. […]

United-states
America
Soroush-salehian-dardashti
Craig-hallum
Magnetar-financial
Oppenheimer-co
Aeva-technologies-company-profile
Aeva-technologies-inc
Securities-exchange-commission
Morgan-stanley
Susquehanna-fundamental-investments
Aeva-technologies

CytomX Therapeutics (NASDAQ:CTMX) Upgraded to Overweight by Piper Sandler

CytomX Therapeutics (NASDAQ:CTMX – Get Free Report) was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a research note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $3.50 price objective on the biotechnology company’s stock, up from their prior price objective of $2.25. Piper […]

Piper-sandler
Seana-mccarthy
Cytomx-therapeutics-inc
Congress-park-capital
Jefferies-financial-group
Cytomx-therapeutics-company-profile
Susquehanna-fundamental-investments
Jpmorgan-chase-co
York-mellon-corp
Sg-americas-securities
Alphamark-advisors
Cytomx-therapeutics

VNET Group (NASDAQ:VNET) Shares Up 10.2%

VNET Group (NASDAQ:VNET) Shares Up 10.2%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states
China
America
Vnet-group-inc
Nasdaq
Group-price-performance
Group-inc
Group-daily
Pacer-advisors-inc
Mirae-asset-global-investments-co
Group-company-profile
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.